K-Lyte/Cl 25 Drug Interactions
Currently displaying 101 drugs known to have a major interaction with K-Lyte / Cl 25 (potassium bicarbonate / potassium chloride).
- 101 major drug interactions
- 25 moderate drug interactions
- 15 minor drug interactions
Major interactions with K-Lyte / Cl 25 (potassium bicarbonate / potassium chloride)
Note: Showing generic names only.
A
B
C
- candesartan
- captopril
- carbinoxamine
- chlorcyclizine
- chlorpheniramine
- chlorpromazine
- clemastine
- clidinium
- clomipramine
- clozapine
- cyclizine
- cyclobenzaprine
- cyproheptadine
D
- darifenacin
- desipramine
- dexbrompheniramine
- dexchlorpheniramine
- dicyclomine
- dimenhydrinate
- diphenhydramine
- disopyramide
- doxepin
- doxepin topical
- doxylamine
E
F
G
H
I
L
M
- maprotiline
- meclizine
- mepenzolate
- mesoridazine
- methdilazine
- methotrimeprazine
- methscopolamine
- moexipril
- molindone
N
O
P
- perindopril
- perphenazine
- phenindamine
- pimozide
- prochlorperazine
- procyclidine
- promazine
- promethazine
- propantheline
- propiomazine
- protriptyline
- pyrilamine
Q
R
S
T
- telmisartan
- thiethylperazine
- thioridazine
- thiothixene
- tolterodine
- trandolapril
- triamterene
- trifluoperazine
- triflupromazine
- trihexyphenidyl
- trimeprazine
- trimethoprim
- trimipramine
- tripelennamine
- triprolidine
- trospium
V
K-Lyte/Cl 25 disease interactions
There are 9 disease interactions with K-Lyte / Cl 25 (potassium bicarbonate / potassium chloride) which include:
- dehydration/diarrhea
- dehydration
- familial periodic paralysis
- hyperkalemia
- renal dysfunction
- GI irritation
- acid/base balance
- alkalosis
- acidosis
More about K-Lyte / Cl 25 (potassium bicarbonate / potassium chloride)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.